Drug intelligence / Profile preview

lyophilized human rabies vaccine

Development stage
Phase 1
Lead developer
Beijing Bohui Innovation Biotechnology
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

**Lyophilized human rabies vaccine (human diploid cell)** is a prophylactic rabies vaccine being developed by **Bohui Instrument Group** for the prevention of rabies in humans. It is described in Bohui's pipeline as a **lyophilized vaccine produced in human diploid cells** and is intended to provide **active immunization** by exposing recipients to rabies virus antigens, thereby inducing protective neutralizing antibody and adaptive immune responses that prevent rabies infection after exposure risk. Based on the company pipeline disclosures provided, the program had received IND approval and was positioned to enter **Phase 1** clinical development for **rabies prevention**.

Other names
冻干人用狂犬病疫苗冻干人用狂犬病疫苗(人二倍体细胞)human rabies vaccinehuman rabies vaccine (human diploid cell)lyophilized human rabies vaccine (human diploid cell)

Beyond the preview

Go deeper on lyophilized human rabies vaccine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lyophilized human rabies vaccine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call